Patents by Inventor Pierre Dilda

Pierre Dilda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHYTOECDYSONES FOR USE IN THE PREVENTION OF MUSCLE STRENGTH LOSS DURING IMMOBILISATION
    Publication number: 20230158046
    Abstract: A composition including at least one phytoecdysone or at least one semi-synthetic derivative of a phytoecdysone, for use in mammals for preventing the loss of muscle strength during immobilisation. More particularly, a composition for use that includes 20-hydroxyecdysone or a semi-synthetic derivative of 20-hydroxyecdysone. Moreover, the composition for use includes a compound of general formula (I).
    Type: Application
    Filed: January 24, 2023
    Publication date: May 25, 2023
    Inventors: Pierre DILDA, Mathilde LATIL, René LAFONT, Stanislas VEILLET
  • PHYTOECDYSONES AND DERIVATIVES THEREOF FOR USE IN TREATING DISORDERED RESPIRATORY FUNCTION ON VIRAL INFECTION
    Publication number: 20230128105
    Abstract: Disclosed are phytoecdysones and semisynthetic derivatives of phytoecdysones, intended to be used in treating impairment of the respiratory function in mammals, in particular in the context of a viral infection and more particularly during an infection by a coronavirus.
    Type: Application
    Filed: March 24, 2021
    Publication date: April 27, 2023
    Inventors: Pierre DILDA, René LAFONT, Stanislas VEILLET, Samuel AGUS, Waly DIOH, Serge CAMELO, Mathilde LATIL, Mounia CHABANE DE SAINT AUBIN, Cendrine TOURETTE
  • CHEMICAL COMPOUNDS TARGETING THE EYE AND USE THEREOF IN THE TREATMENT OF EYE DISEASES
    Publication number: 20230089459
    Abstract: Disclosed is chemical compounds C that are derivatives of norbixin and have tropism for the eye, and are intended to be used in the treatment of eye diseases in mammals, in particular in the context of altering the retinal pigment epithelium and more particularly in the context of age-related macular degeneration (AMD) and Stargardt's disease.
    Type: Application
    Filed: December 22, 2020
    Publication date: March 23, 2023
    Inventors: Laurence DINAN, René LAFONT, Pierre DILDA, Serge CAMELO, Valérie FONTAINE, Christine BALDUCCI, Elodie MONTEIRO, Louis GUIBOUT, Mathilde LATIL, José-Alain SAHEL, Stanislas VEILLET
  • Use of 20-hydroxyecdysone and the derivatives thereof in the treatment of myopathies
    Patent number: 11542295
    Abstract: The invention relates to 20-hydroxyecdysone and the derivatives thereof, for use in the treatment of genetic myopathies.
    Type: Grant
    Filed: April 27, 2018
    Date of Patent: January 3, 2023
    Assignees: BIOPHYTIS, SORBONNE UNIVERSITÉ
    Inventors: Pierre Dilda, René Lafont, Mathilde Latil, Maria Serova, Onnik Agbulut, Stanislas Veillet
  • Pharmaceutical combinations of organo-arsenoxide compounds and mTOR inhibitors
    Patent number: 11452735
    Abstract: The present invention relates to synergistic pharmaceutical combinations comprising organic arsenoxide compounds and mTOR inhibitors. Further, the present invention relates to the use of these pharmaceutical combinations in therapy, in particular, treatment of proliferative diseases.
    Type: Grant
    Filed: June 29, 2020
    Date of Patent: September 27, 2022
    Inventors: Philip John Hogg, Pierre Dilda
  • PHYTOECDYSONES AND THE DERIVATIVES THEREOF FOR USE IN THE TREATMENT OF NEUROMUSCULAR DISEASES
    Publication number: 20220160732
    Abstract: Disclosed are 20-hydroxyecdysone and the derivatives thereof, intended for use in the treatment of a neuromuscular disease such as spinal muscular atrophy or amyotrophic lateral sclerosis, or more particularly in the treatment of a specific disorder of the motor neurons causing alterations in the muscular function occurring in the context of these neuromuscular diseases.
    Type: Application
    Filed: March 12, 2020
    Publication date: May 26, 2022
    Inventors: Mathilde LATIL, Pierre DILDA, René LAFONT, Stanislas VEILLET
  • PHYTOECDYSONES AND THE DERIVATIVES THEREOF FOR USE IN THE TREATMENT OF IMPAIRED LUNG FUNCTION
    Publication number: 20220152060
    Abstract: Disclosed are phytoecdysones and the derivatives thereof, intended for use in the treatment of impaired lung function in mammals, in particular in the context of a neuromuscular disease and more particularly when the impaired lung function is linked to a deterioration of the mechanical properties of the lung tissue.
    Type: Application
    Filed: March 12, 2020
    Publication date: May 19, 2022
    Inventors: Mathilde LATIL, Pierre DILDA, René LAFONT, Stanislas VEILLET
  • PHYTOECDYSONES FOR USE IN THE PREVENTION OF MUSCLE STRENGTH LOSS DURING IMMOBILISATION
    Publication number: 20210369735
    Abstract: A composition including at least one phytoecdysone or at least one semi-synthetic derivative of a phytoecdysone, for use in mammals for preventing the loss of muscle strength during immobilisation. More particularly, a composition for use that includes 20-hydroxyecdysone or a semi-synthetic derivative of 20-hydroxyecdysone. Moreover, the composition for use includes a compound of general formula (I).
    Type: Application
    Filed: February 20, 2019
    Publication date: December 2, 2021
    Inventors: Pierre DILDA, Mathilde LATIL, René LAFONT, Stanislas VEILLET
  • Pharmaceutical Combinations of Organo-Arsenoxide Compounds and mTOR Inhibitors
    Publication number: 20200323887
    Abstract: The present invention relates to synergistic pharmaceutical combinations comprising organic arsenoxide compounds and mTOR inhibitors. Further, the present invention relates to the use of these pharmaceutical combinations in therapy, in particular, treatment of proliferative diseases.
    Type: Application
    Filed: June 29, 2020
    Publication date: October 15, 2020
    Inventors: Philip John Hogg, Pierre Dilda
  • USE OF 20-HYDROXYECDYSONE AND THE DERIVATIVES THEREOF IN THE TREATMENT OF MYOPATHIES
    Publication number: 20200179407
    Abstract: The invention relates to 20-hydroxyecdysone and the derivatives thereof, for use in the treatment of genetic myopathies.
    Type: Application
    Filed: April 27, 2018
    Publication date: June 11, 2020
    Applicants: BIOPHYTIS, SORBONNE UNIVERSITE
    Inventors: Pierre DILDA, René LAFONT, Mathilde LATIL, Maria SEROVA, Onnik AGBULUT, Stanislas VEILLET
  • PHARMACEUTICAL-GRADE 20-HYDROXYECDYSONE EXTRACT, USE OF SAME AND PREPARATION THEREOF
    Publication number: 20200148718
    Abstract: The invention concerns a method for preparing an extract from a preparation of approximately 90% pure 20-hydroxyecdysone that comprises the following steps: g) Hot dissolution of approximately 90% pure 20-hydroxyecdysone in methanol, filtration and partial concentration, h) Addition of 1 to 5 volumes of acetone, i) Cooling to a temperature of between 0 and 5° C. while stirring, j) Filtration of the obtained precipitate, k) Successive rinses with acetone and water, and l) Drying.
    Type: Application
    Filed: April 30, 2018
    Publication date: May 14, 2020
    Applicants: BIOPHYTIS, SORBONNE UNIVERSITE
    Inventors: René LAFONT, Pierre DILDA, Waly DIOH, Philippe DUPONT, Susanna DEL SIGNORE, Stanislas VEILLET
  • Pharmaceutical Combinations of Organo-Arsenoxide Compounds and mTOR Inhibitors
    Publication number: 20180140620
    Abstract: The present invention relates to synergistic pharmaceutical combinations comprising organic arsenoxide compounds and mTOR inhibitors. Further, the present invention relates to the use of these pharmaceutical combinations in therapy, in particular, treatment of proliferative diseases.
    Type: Application
    Filed: June 15, 2015
    Publication date: May 24, 2018
    Inventors: Philip John Hogg, Pierre Dilda
  • Organo-arsenoxide compounds and use thereof
    Patent number: 9765101
    Abstract: The present invention relates to organo-arsenoxide compounds and to methods for their synthesis. The invention also relates to pharmaceutical compositions comprising these compounds and to their use in the treatment of diseases and disorders, in particular proliferative diseases and disorders, including treatment of solid tumors and leukaemia.
    Type: Grant
    Filed: August 16, 2012
    Date of Patent: September 19, 2017
    Assignee: NewSouth Innovations Pty Limited
    Inventors: Philip John Hogg, Pierre Dilda
  • Organo-Arsenoxide Compounds and Use Thereof
    Publication number: 20130041027
    Abstract: The present invention relates to organo-arsenoxide compounds and to methods for their synthesis. The invention also relates to pharmaceutical compositions comprising these compounds and to their use in the treatment of diseases and disorders, in particular proliferative diseases and disorders, including treatment of solid tumors and leukaemia.
    Type: Application
    Filed: August 16, 2012
    Publication date: February 14, 2013
    Applicant: NewSouth Innovations Pty Limited
    Inventors: Philip John Hogg, Pierre Dilda
  • Organo-arsenoxide compounds and use thereof
    Patent number: 8268883
    Abstract: The present invention relates to organo-arsenoxide compounds and to methods for their synthesis. The invention also relates to pharmaceutical compositions comprising these compounds and to their use in the treatment of diseases and disorders, in particular proliferative diseases and disorders, including treatment of solid tumors and leukaemia.
    Type: Grant
    Filed: November 1, 2007
    Date of Patent: September 18, 2012
    Assignee: Newsouth Innovations Pty Limited
    Inventors: Philip John Hogg, Pierre Dilda
  • Organo-Arsenoxide Compounds and Use Thereof
    Publication number: 20100041749
    Abstract: The present invention relates to organo-arsenoxide compounds and to methods for their synthesis. The invention also relates to pharmaceutical compositions comprising these compounds and to their use in the treatment of diseases and disorders, in particular proliferative diseases and disorders, including treatment of solid tumors and leukaemia.
    Type: Application
    Filed: November 1, 2007
    Publication date: February 18, 2010
    Applicant: NEWSOUTH INNOVATIONS PTY LIMITED
    Inventors: Philip John Hogg, Pierre Dilda